We are live on ! Find out more
TSRX

TRIUS THERAPEUTICS INC COM STK (DE)
TSRX

Delisted

TSRX was delisted on the 11th of September, 2013.

Back to rankings

7 hedge funds and large institutions have $529K invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 3 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% less funds holding

Funds holding: 84 → 7 (-77)

96% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 79

100% less capital invested

Capital invested by funds: $145M → $529K (-$144M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
7
Holders Change
-77
Holders Change %
-91.67%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
3
Closed
79
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Amici Capital
New York
+$5.16M
2
FCH
Freestone Capital Holdings
Washington
+$197K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$21M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$14M
3
First Eagle Investment Management
First Eagle Investment Management
New York
-$13.6M
4
BFA
BlackRock Fund Advisors
California
-$11.2M
5
UBS AM
UBS AM
Illinois
-$9.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
– -$1.84M -227,272 Closed
RFC
27
Russell Frank Company
Washington
– -$1.72M -222,427 Closed
TCIM
28
TIAA CREF Investment Management
New York
– -$1.71M -210,604 Closed
HCM
29
Highbridge Capital Management
New York
– -$1.7M -209,816 Closed
Morgan Stanley
30
Morgan Stanley
New York
– -$1.58M -194,492 Closed
Millennium Management
31
Millennium Management
New York
– -$1.53M -189,135 Closed
JP Morgan Chase
32
JP Morgan Chase
New York
– -$1.26M -155,184 Closed
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
– -$1.23M -151,263 Closed
SKK
34
Shepherd Kaplan Krochuk
Massachusetts
– -$1.12M -138,811 Closed
PC
35
Polar Capital
United Kingdom
– -$1.1M -135,899 Closed
Ameriprise
36
Ameriprise
Minnesota
– -$1.1M -134,966 Closed
CS
37
Credit Suisse
Switzerland
– -$1.09M -134,179 Closed
Geode Capital Management
38
Geode Capital Management
Massachusetts
– -$1.05M -129,219 Closed
CCM
39
Cadence Capital Management
Massachusetts
– -$1.02M -126,389 Closed
WFI
40
West Family Investments
California
– -$894K -110,424 Closed
Group One Trading
41
Group One Trading
Illinois
– -$880K -108,316 Closed
BIM
42
BlackRock Investment Management
Delaware
– -$799K -98,645 Closed
Schroder Investment Management Group
43
Schroder Investment Management Group
United Kingdom
– -$714K -88,094 Closed
BCM
44
Bridgeway Capital Management
Texas
– -$648K -80,000 Closed
Charles Schwab
45
Charles Schwab
California
– -$601K -72,555 Closed
Renaissance Technologies
46
Renaissance Technologies
New York
– -$527K -65,061 Closed
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
– -$527K -64,867 Closed
NFA
48
Nationwide Fund Advisors
Ohio
– -$524K -64,552 Closed
UCFA
49
United Capital Financial Advisors
Texas
– -$484K -59,790 Closed
PPA
50
Parametric Portfolio Associates
Washington
– -$483K -59,626 Closed
1
2
3 4

TSRX Hedge Fund Activity: Q3 2013 in Review

7 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q3 2013, worth a combined $529K — down 100% from $145M a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of TSRX and 3 opened new positions — a net loss of 76 holders — while 3 trimmed existing stakes and 0 added.

The largest buyer was Amici Capital, opening a new position worth an estimated $5.16M. The largest seller was Wellington Management Group, exiting entirely with an estimated $21M sold.

  • 7 institutional investors held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q3 2013, down from 84 in Q2 2013.
  • Funds reported $529K of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q3 2013, down 100% quarter-over-quarter.
  • 3 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q3 2013 and 79 closed out, a net change of -76 holders.
  • The largest TRIUS THERAPEUTICS INC COM STK (DE) buyer in Q3 2013 was Amici Capital, an estimated $5.16M added.
  • The largest TRIUS THERAPEUTICS INC COM STK (DE) seller in Q3 2013 was Wellington Management Group, an estimated $21M sold.

Based on aggregated 13F filings for Q3 2013.